Volumetric and Dosimetric Assessment by Cone-Beam Computed Tomography Scans in Head and Neck Radiation Therapy: A Monitoring in Four Phases of Treatment

Abstract

Due to the anatomical changes frequently occurring during the course of head and neck (H&N) cancer radiotherapy, the dose distribution, which was actually delivered to the patient, might significantly differ from that planned. The aim of this paper is to investigate these volumetric changes and the resulting dosimetric implications on organs at risk (OARs) and clinical target volumes (CTVs) by cone beam computed tomography (CBCT) scans throughout the treatment. Ten H&N patients, treated by Intensity Modulated Radiotherapy, were analyzed. CTVs and OARs were delineated on four CBCT, acquired at the 10^th, 15^th, 20^th and 25^th treatment session, and then compared with the ones at planning CT. The planned beams were applied to each CBCT to recalculate the dose distribution and the corresponding dose volume histograms were compared with those generated on planning CT. To evaluate the HU discrepancies between the conventional CT and CBCT images we used a Catphan® 504, observing a maximum discrepancy of about 30 HU. We evaluated the impact of this HU difference in dose calculation and a not clinically relevant error, within 2.8%, was estimated. No inhomogeneity correction was used. The results showed an increased CTV mean dose (D_mean) of about 3% was found, without significant reduction in volume. Due to the parotids' shrinkage (up to 42%), significant dosimetric increases were observed: ipsilateral gland at 15^th CBCT (D_mean by 18%; V30 by 31%); controlateral gland at the 10^th CBCT (D_mean by 12.2%; V30 by 18.7%). For the larynx, a significant increase of volume was found at the 20^th (15.7%) and 25^th CBCT (13.3%) but it complied with dose constraint. The differences observed for the spinal cord and mandible maximum doses were not clinically relevant. In conclusion, the dosimetric analysis on CBCT can help clinicians to monitor treatment progress and to evaluate whether and when a new plan is necessary. The main benefit of replanning could be to preserve the parotids and our data support the hypothesis that the 3^rd week of radiotherapy should be a check point for parotids.

Keywords

Cone beam CT Head and neck cancer Replanning Volume changes Dosimetric changes

References

Ricchetti

McNutt

Wong

Forastiere

Marur

Starmer

Sanguineti

Volumetric change of selected organs at risk during IMRT for oropharyngeal cancer. Int J Radiation Oncology Biol Phys 80, 1 161–168 (2011). DOI: 10.1016/j.ijrobp.2010.01.071.

Lee

Q. T.

Xing

Retrospective IMRT dose reconstruction based on cone-beam CT and MLC log-file. Int J Radiat Oncol Biol Phys 70 (2), 634–44 (2008). DOI: 10.1016/j.ijrobp.2007.09.054.

Barker

J. L.

Jr. Garden

A. S.

Ang

K. K.

Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head and neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys 59, 960–970 (2004). DOI: 10.1016/j.ijrobp.2003.12.024.

Fiorentino

Caivano

Metallo

Chiumento

Cozzolino

Califano

Clemente

Pedicini

Fusco

Parotid gland volumetric changes during intensity-modulated radiotherapy in head and neck cancer. Br J Radiol 85, 1415–1419 (2012). DOI: 10.1259/bjr/30678306.

Hector

C. L.

Webb

Evans

P. M.

The dosimetric consequences of interfractional patient movement on conventional and intensity-modulated breast radiotherapy treatments. Radiother Oncol 54, 57–64 (2000). DOI: 10.1016/S0167-8140(99)00167-X.

Hansen

E. K.

Bucci

M. K.

Quivey

J. M.

Weinberg

Xia

Repeat CT imaging and replanning during the course of IMRT for head and neck cancer. Int J Radiat Oncol Biol Phys 64 (2), 355–362 (2006). DOI: 10.1016/j.ijrobp.2005.07.957.

Chi

Chen

P. Y.

Krauss

D. J.

Yan

Martinez

Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiation Oncology Biol Phys 75 (3), 924–932 (2009). DOI: 10.1016/j.ijrobp.2009.04.047.

Osorio

E. M. Vasquez

Hoogeman

M. S.

Al-Mamgani

Teguh

D. N.

Levendag

P. C.

Heijmen

B. J.

Local anatomic changes in parotid and submandibular glands during radiotherapy for oropharynx cancer and correlation with dose, studied in detail with nonrigid registration. Int J Radiat Oncol Biol Phys 70 (3), 875–882 (2008). DOI: 10.1016/j.ijrobp.2007.10.063.

Yoo

Yin

F. F.

Dosimetric feasibility of cone-beam CT-based treatment planning compared to CT-based treatment planning. Int J Radiation Oncology Biol Phys 66 (5), 1553–1561 (2006). DOI: 10.1016/j.ijrobp.2006.08.031.

10.

Ding

G. X.

Duggan

D. M.

Coffey

C. W.

Deeley

Hallahan

D. E.

Cmelak

Malcolm

A study on adaptive IMRT treatment planning using kV cone-beam CT. Radiotherapy and Oncology 85, 116–125 (2007). DOI: 10.1016/j.radonc.2007.06.015.

11.

Hatton

J. A.

Greer

P. B.

Tang

Wright

Capp

Gupta

Parker

Wratten

Denham

J. W.

Does the planning dose-volume histogram represent treatment doses in image-guided prostate radiation therapy? Assessment with cone-beam computerised tomography scans. Radiotherapy and Oncology 98, 162–168 (2011). DOI: 10.1016/j.radonc.2011.01.006.

12.

www.rtog.com .

13.

Marks

B. L.

Yorke

E. D.

Jackson

Haken

R. K. T.

Constine

L. S.

Eisbruch

Bentzen

S. M.

Nam

Deasy

J. O.

Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 76 (3), 10–19 (2010). DOI: 10.1016/j.ijrobp.2009.07.1754.

14.

Palm

Nilsson

Herrnsdorf

Absorbed dose and dose rate using the Varian OBI v.1.3 and 1.4 CBCT system. J Appl Clin Med Phys 11 (1), 3085 (2010). PMID: 20160695.

15.

Ding

G. X.

Munro

Pawlowski

Malcom

Coffey

C. W.

Reducing radiation exposure to patients from Kv-CBCT imaging. Radiother Oncol 97, 585–92 (1997). DOI: 10.1016/j.radonc.2010.08.005.

16.

K. F.

Marchant

Moore

Webster

Rowbottom

Penington

Lee

Yap

Sykes

Slevin

Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy. J Radiat Oncol Biol Phys 82 (3), 375–82 (2012). DOI: 10.1016/j.ijrobp.2011.07.004.

17.

Bhide

S. A.

Davies

Burke

McNair

H. A.

Hansen

Barbachano

El-Hariry

I. A.

Newbold

Harrington

K. J.

Nutting

C. M.

Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: A prospective observational study. Int J Radiation Oncology Biol Phys 76 (5), 1360–1368 (2010). DOI: 10.1016/j.ijrobp.2009.04.005.

18.

Loo

Fairfoul

Chakrabarti

Dean

J. C.

Benson

R. J.

Jefferies

S. J.

Burnet

N. G.

Tumour shrinkage and contour change during radiotherapy increase the dose to organs at risk but not the target volumes for head and neck cancer patients treated on the Tomo-Therapy HiArt™ system. Clin Oncol (R Coll Radiol) 23 (1), 40–7 (2011). DOI: 10.1016/j.clon.2010.09.003.

19.

Nishimura

Nakamatsu

Shibata

Kanamori

Okumura

M. Koike

Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancer treated with IMRT. Jpn J Clin Oncol 35, 375–379 (2005). DOI:10.1093/jjco/hyi108.

20.

Zhao

Han

L. X.

Huang

S. M.

Lin

C. G.

Deng

X. W.

T. X.

Cui

N. J.

Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma. Chinese Journal of Cancer 23 (11 Suppl.), 1532–1537 (2004). PMID: 15566674.

21.

Castadot

Lee

J. A.

Geets

Grégoire

Adaptive radiotherapy of head and neck cancer. Semin Radiat Oncol 20 (2), 84–93 (2010). DOI: 10.1016/j.semradonc.2009.11.002.